Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Ghuysen

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Cardiovascular Drug Reviews|May 4, 2005
Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitorAlexandre Ghuysen, Jean-Michel Dogné, Patrice Chiap, et al.
Journal of Cardiovascular Pharmacology|January 18, 2005
Effects of dobutamine on left ventriculoarterial coupling and mechanical efficiency in acutely ischemic pigsPhilippe Kolh, Bernard Lambermont, Alexandre Ghuysen, et al.
BMC Medical Education|April 19, 2024
Collaborative virtual reality environment in disaster medicine: moving from single player to multiple learnersLaure Abensur Vuillaume, Jonathan Goffoy, Nadège Dubois, et al.
Physiological Measurement|November 25, 2010
Subject-specific cardiovascular system model-based identification and diagnosis of septic shock with a minimally invasive data set: animal experiments and proof of conceptJ Geoffrey Chase, Bernard Lambermont, Christina Starfinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolismAlexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, et al.
Prostaglandins & Other Lipid Mediators|November 24, 2005
Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pigVincent Tchana-Sato, Jean-Michel Dogné, Bernard Lambermont, et al.
Computational and Mathematical Methods in Medicine|April 16, 2013
Evaluation of a model-based hemodynamic monitoring method in a porcine study of septic shockJames A Revie, David Stevenson, J Geoffrey Chase, et al.
Plos One|March 11, 2021
Clinical decision support tool for diagnosis of COVID-19 in hospitalsClaude Saegerman, Allison Gilbert, Anne-Françoise Donneau, et al.
Computer Methods and Programs in Biomedicine|February 7, 2012
Assessment of ventricular contractility and ventricular-arterial coupling with a model-based sensorThomas Desaive, Bernard Lambermont, Nathalie Janssen, et al.
Shock (Augusta, Ga.)|December 17, 2003
Effect of a novel thromboxane A2 inhibitor on right ventricular-arterial coupling in endotoxic shockBernard Lambermont, Philippe Kolh, Alexandre Ghuysen, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Cardiovascular Drug Reviews|May 4, 2005
Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitorAlexandre Ghuysen, Jean-Michel Dogné, Patrice Chiap, et al.
Journal of Cardiovascular Pharmacology|January 18, 2005
Effects of dobutamine on left ventriculoarterial coupling and mechanical efficiency in acutely ischemic pigsPhilippe Kolh, Bernard Lambermont, Alexandre Ghuysen, et al.
BMC Medical Education|April 19, 2024
Collaborative virtual reality environment in disaster medicine: moving from single player to multiple learnersLaure Abensur Vuillaume, Jonathan Goffoy, Nadège Dubois, et al.
Physiological Measurement|November 25, 2010
Subject-specific cardiovascular system model-based identification and diagnosis of septic shock with a minimally invasive data set: animal experiments and proof of conceptJ Geoffrey Chase, Bernard Lambermont, Christina Starfinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolismAlexandre Ghuysen, Bernard Lambermont, Jean-Michel Dogné, et al.
Prostaglandins & Other Lipid Mediators|November 24, 2005
Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pigVincent Tchana-Sato, Jean-Michel Dogné, Bernard Lambermont, et al.
Computational and Mathematical Methods in Medicine|April 16, 2013
Evaluation of a model-based hemodynamic monitoring method in a porcine study of septic shockJames A Revie, David Stevenson, J Geoffrey Chase, et al.
Plos One|March 11, 2021
Clinical decision support tool for diagnosis of COVID-19 in hospitalsClaude Saegerman, Allison Gilbert, Anne-Françoise Donneau, et al.
Computer Methods and Programs in Biomedicine|February 7, 2012
Assessment of ventricular contractility and ventricular-arterial coupling with a model-based sensorThomas Desaive, Bernard Lambermont, Nathalie Janssen, et al.
Shock (Augusta, Ga.)|December 17, 2003
Effect of a novel thromboxane A2 inhibitor on right ventricular-arterial coupling in endotoxic shockBernard Lambermont, Philippe Kolh, Alexandre Ghuysen, et al.
Pageof 10